London: The AstraZeneca vaccine was given to people around the world. Especially in India, its vaccine Covishield was used extensively. Now it has come to light that those taking it are experiencing fatal side effects. This vaccine has been reported to cause TTS syndrome. After the Corona virus epidemic in 2020, AstraZeneca company prepared its vaccine. In India, the Serum Institute jointly produced AstraZeneca with Oxford University under the name Covishield. The AstraZeneca vaccine (Covishield), which was prepared for the first time in 2021, has been continuously under question. Many countries had banned this vaccine in 2021 itself.
It was then that questions started being raised in the scientific community on the speed with which Covishield was prepared. After this, investigation started regarding whether the vaccine was safe in its work or not. The vaccine was also brought under question for incidents of heart attack. According to the report of an English newspaper, the questions raised by medical experts on this vaccine have now been strengthened. It has been claimed about AstraZeneca that this vaccine caused some deaths and many people had to face serious diseases. British pharmaceutical company AstraZeneca has also admitted that their vaccine can have dangerous side effects.
In documents submitted to the British High Court, the company admitted that their vaccine could cause thrombosis called thrombocytopenia syndrome (TTS). In India too, this vaccine was given to a large number of people after the arrival of Covid. The AstraZeneca vaccine is known as AZD1222 or Covishield in India. It is a viral vector vaccine designed to protect against the SARS-CoV-2 virus, the causative agent of COVID-19.
Talking about the way this virus works, it works by using a weakened version of a common cold virus (adenovirus) found in chimpanzees. It has been modified to carry the gene for a protein from the SARS-CoV-2 virus. After being injected into the body, the vaccine stimulates the human immune system to produce antibodies and activate T-cells so that the human body can fight the virus that causes infection. Talking about the development of AstraZeneca vaccine, this vaccine was developed in collaboration between Oxford University and British-Swedish pharmaceutical company AstraZeneca. Oxford researchers had been developing a vaccine using adenovirus vectors for some years. After the arrival of the Covid pandemic, he rapidly stepped up his efforts towards making a vaccine against the corona virus.
Vaccine entry in India
Pune-based pharma company Serum Institute of India signed a deal with AstraZeneca and Oxford University in January 2021 to manufacture the Covishield vaccine for India and some other poor countries. This partnership allowed Serum to mass produce the vaccine under the name Covishield to meet the huge demand in India and globally. After the creation of Covishield, its distribution in India was facilitated with the cooperation of the Government of India and State Governments and the vaccine was delivered to the people.
Over 1.7 billion doses of Covishield to be administered in India by 2022 as part of the world’s largest vaccination programme. The simple storage and wide availability of the AstraZeneca vaccine played a vital role in vaccination campaigns in India and around the world. The vaccine was delivered to a large number of common people in India.
Vaccine banned due to side effects
The World Health Organization (WHO) lists the side effects of the AstraZeneca vaccine. This includes mild to moderate symptoms. Side effects reported after receiving the AstraZeneca vaccine include injection site discomfort, feeling sick, fatigue, fever, headache, feeling sick, joint or muscle pain, swelling, redness at the injection site, dizziness, sleepiness. , sweating, stomach pain, and fainting. It was then said that these side effects are temporary and resolve without the need for hospitalization. After closer scrutiny of the AstraZeneca vaccine, it was banned in many countries. Denmark was the first country to ban the Covid-19 vaccine AstraZeneca. After this, Ireland, Thailand, Netherlands, Norway, Iceland, Congo and Bulgaria also banned it.
European countries including Germany, France, Italy and Spain also stopped using AstraZeneca’s Covid-19 vaccine in 2021 after several cases of blood clots were reported in patients who were inoculated. Canada, Sweden, Latvia and Slovenia also halted its use in 2021. After this, considering this vaccine as not safe, it was banned in Australia, Indonesia and Malaysia.
America bans three Indian companies for helping Iran
Thrombosis with thrombocytopenia syndrome (TTS) is a rare but serious disease associated with the vaccine. Particularly adenovirus vector vaccines such as the AstraZeneca vaccine and Johnson & Johnson’s Janssen vaccine. The condition TTS involves the formation of blood clots along with having low platelet levels. This condition usually occurs along with blood clots in the brain or stomach.
